Similarly, we observed inhibition of total β-Catenin (Fig. 7E, F; lanes 3 and 4), as well as its downstream cMyc (Fig. 7G, H; lanes 3 and 4), in the nuclear fraction of tumor organoids treated with 5-FU and RT. The gene discussed is MYC; the disease is neoplasm.